Will doxorubicin cause hair loss when used? Probability of side effects and prevention methods

Doxorubicin (Doxorubicin) is a commonly used chemotherapy drug that is widely used in the treatment of malignant tumors such as breast cancer, lymphoma, and leukemia. As an anthracycline anticancer drug, doxorubicin exerts anti-tumor effects by inhibiting DNA replication and transcription in cancer cells. However, like many chemotherapy drugs, it also affects normal, rapidly dividing cells, and one of the most obvious side effects is hair loss.

Clinical data show that the incidence of hair loss caused by doxorubicin is relatively high, ranging from 60% to 90%. It usually appears gradually 2 to 4 weeks after the start of chemotherapy, and the hair loss area is mostly covering the entire scalp, and may also affect eyebrows, eyelashes and body hair. Although hair loss is a reversible side effect, it will have a certain negative psychological impact on patients, especially female patients. Therefore, patients should be fully informed of possible hair loss before treatment in order to be mentally prepared.

Methods to prevent hair loss caused by doxorubicin mainly include physical and nursing measures. In terms of physical aspects, scalp cooling caps are a common means to reduce the exposure of drugs to hair follicles by reducing local blood flow, thereby reducing the risk of hair loss. In terms of care, patients should choose mild shampoo, avoid perming and dyeing, reduce the use of high-temperature hair dryers and tight hairstyles to reduce mechanical and chemical stimulation of hair follicles. At the same time, a balanced diet and supplement of protein, vitamins and trace elements can also help hair recovery.

Despite preventive measures, some patients may still experience hair loss, but most people can gradually regenerate hair within 6 to 12 months after completing chemotherapy. The medical team should pay attention to the patient's psychological state during the treatment process and provide necessary psychological counseling and appearance support, such as suggestions on the use of wigs or headscarves. At the same time, regular follow-up and monitoring of changes in side effects can help to timely adjust the chemotherapy regimen or take additional intervention measures to minimize the impact of hair loss and other adverse reactions on the patient's quality of life.

Reference materials:https://www.drugs.com/